SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:f1145985-cace-4ae9-87a4-793138e89c59"
 

Search: onr:"swepub:oai:lup.lub.lu.se:f1145985-cace-4ae9-87a4-793138e89c59" > Current European pr...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Astermark, JanLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine (author)

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

  • Article/chapterEnglish2006

Publisher, publication year, extent ...

  • Wiley,2006

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:f1145985-cace-4ae9-87a4-793138e89c59
  • https://lup.lub.lu.se/record/159058URI
  • https://doi.org/10.1111/j.1365-2516.2006.01296.xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • The management of patients with inhibitors is an important challenge in haemophilia care. The lack of randomized controlled trials means that clinical decisions are generally based on subjective opinions, and purchasers' attention is likely to focus on the costs of treatment. In order to assess the current management of inhibitor patients and use of immune tolerance induction therapy (ITI) in Europe, we performed a survey within a European network of 21 comprehensive care centres from 14 countries (the European Haemophilia Therapy Standardisation Board). The survey identified a total of 381 patients with inhibitors attending the centres, 211 (55.4%) of whom had never been exposed to ITI. Between 1998 and 2003, the centres performed 233 procedures and 114 (48.9%) were successful. The survey demonstrated that dosing, which is the time to start and stop the ITI, the type of concentrate to use and the definition of success varied among the centres. Well-designed trials are warranted to guide decision-making, but in the absence of these studies we have developed consensus guidance for the management of inhibitor patients based on current clinical practice, as identified by the survey, and review of the literature.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Morado, M (author)
  • Rocino, A (author)
  • van den Berg, H M (author)
  • von Depka, M (author)
  • Gringeri, A (author)
  • Mantovani, L (author)
  • Garrido, R P (author)
  • Schiavoni, M (author)
  • Villar, A (author)
  • Windyga, J (author)
  • Institutionen för kliniska vetenskaper, MalmöMedicinska fakulteten (creator_code:org_t)

Related titles

  • In:Haemophilia: Wiley12:4, s. 363-3711351-82161365-2516

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view